Stomatitis: Clinical Trials

56 trials for Stomatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 11 unknown, 5 terminated, 4 recruiting. 56 Phase 3, 13 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 356Completed 33, Unknown 11, Terminated 5, Recruiting 4, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 213Completed 6, Unknown 4, Terminated 2, Recruiting 1

Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis

Trials (filtered) newest first · largest first

All 56 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis
alpha lipoic acid 600 mg twice daily, Placebo Tablet - Colorectal Cancer
Phase 2 / Phase 3RecruitingAin Shams University502026-07-272026-07-30
A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.
BupiZenge 25 mg, Lidocaine viscous 2% - Head & Neck Cancer, Oral Mucositis
Phase 3RecruitingOncoZenge AB1502026-07-072026-10-27
Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM)
Modified Dahuang Huanglian Xiexin Mouthwash, Placebo Mouthwash - Radiotherapy-Induced Oral Mucositis, Stomatitis
Phase 3Not yet recruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1562026-04-302026-04-22
Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations
BALI association, Placebo - Aphthous Stomatitis
Phase 3UnknownEMS2322024-09-012024-02-16
Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients
N-Acetylcysteine 600mg/tab, Placebo - Oral Mucositis, Hematopoietic Stem Cell Transplantation (HSCT)
Phase 3Active not recruitingTehran University of Medical Sciences1062024-08-182026-01-08
Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis
glutamine combined with thalidomide, glutamine alone - Mucositis Oral
Phase 3CompletedAir Force Military Medical University, China1382023-09-152026-07-01
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
Double low-power laser therapy simultaneous applicated - Hematopoietic Stem Cell Transplantation, Low-Level Light Therapy
Phase 3RecruitingInstituto Nacional de Cancer, Brazil842023-08-012023-10-06
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse, Methylene Blue Oral Rinse - Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Phase 3CompletedMayo Clinic492023-06-062025-04-30
NATIENS: Optimal Management and Mechanisms of SJS/TEN
Harmonized supportive care, Etanercept 50 mg sc day 1 and day 4 - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses
Phase 3CompletedVanderbilt University Medical Center22023-03-212025-12-17
A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis
MEBO Wound Ointment (MEBO), Tantum Verde® mouthwash - Oral Mucositis (Ulcerative) Due to Radiation
Phase 3CompletedCairo University362023-03-012025-09-22
Efficacy of EGF-loaded Self Healing Gel in Treatment of Oral Mucositis
EGF loaded Hydrogel, Hydrogel - Oral Mucositis
Phase 2 / Phase 3UnknownCairo University902022-06-012021-08-06
Severe Bullous Drug Eruption and Filgrastim
Filgrastim, Placebo - Rare Diseases, Toxic Epidermal Necrolyses
Phase 2 / Phase 3UnknownHospices Civils de Lyon422022-05-132024-05-08
Omega-3 Hydrogel and Prevention of Oral Mucositis
topical oral Omega-3 hydrogel, conventional preventive treatment - Mucositis Oral
Phase 2 / Phase 3CompletedBasma Morsy362022-02-092023-01-31
Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Benzydamine Hydrochloride, Solcoseryl and pumpkin seed oil - Mucositis Oral
Phase 3UnknownGhada zaki542021-12-012021-08-06
Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Alfacalcidol Oral Solution, Placebo - Oral Squamous Cell Carcinoma, Oral Mucositis
Phase 2 / Phase 3UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University4122021-06-142023-08-29
Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.
Clonidine HCl Mucoadhesive Buccal Tablet, Placebo Mucoadhesive Buccal Tablet - Chemoradiotherapy-Induced Severe Oral Mucositis
Phase 2 / Phase 3TerminatedMonopar Therapeutics1902021-02-112023-05-31
Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT
compound Staphylococcal lysostaphin mouthrinse, chlorhexidine mouthrinse - Stem Cell Transplant Complications, Oral Mucositis
Phase 3CompletedZhejiang University3882020-01-022025-01-24
Comparative Efficacy of Rebamipide Gargle And Benzydamine HCL Gargle in Prevention and Management of Chemo- and Radio-therapy-induced Oral Mucositis
Ribamipide gargle \benzdymine HCL gargel - Oral Mucositis
Phase 3UnknownCairo University1002019-12-262020-12-28
Topical Hyaluronic Acid and Recurrent Aphthous Stomatitis.
Hyaluronic acid in the form of hyaluronan sodium 25 mg/100 ml as a mouthwash - Recurrent Aphthous Stomatitis
Phase 3CompletedCairo University342019-11-012020-02-11
Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation.
Selenium, Placebos - Mucositis Oral, Stem Cell Transplant Complications
Phase 3CompletedUniversity Hospital, Angers1002019-10-102024-12-30

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Head and Neck Neoplasms (11)  ·  Mucositis (8)  ·  Neoplasms (8)  ·  Stevens-Johnson Syndrome (5)  ·  Carcinoma, Squamous Cell (4)  ·  Oral Ulcer (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Stomatitis, Aphthous (3)  ·  Ulcer (3)  ·  Candidiasis, Oral (2)  ·  Inflammation (2)  ·  Oropharyngeal Neoplasms (2)  ·  Pain (2)  ·  Radiation Injuries (2)

Broader conditions

Mouth Diseases (56)  ·  Stomatognathic Diseases (56)  ·  Neoplasms by Site (17)  ·  Neoplasms (14)  ·  Digestive System Diseases (11)  ·  Gastrointestinal Diseases (10)  ·  Neoplasms by Histologic Type (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Gastroenteritis (8)  ·  Neoplasms, Glandular and Epithelial (8)  ·  Carcinoma (7)  ·  Immune System Diseases (6)  ·  Pathologic Processes (6)  ·  Chemically-Induced Disorders (5)

Interventions

Fibroblast Growth Factor 7 (5)  ·  Low-Level Light Therapy (5)  ·  Benzydamine (2)  ·  Glutamine (2)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  Acetylcysteine (1)  ·  Actihaemyl (1)  ·  Anthocyanins (1)  ·  Anti-Inflammatory Agents (1)  ·  Ascorbic Acid (1)  ·  Biotene (1)  ·  Cisplatin (1)  ·  Diphenhydramine (1)  ·  Etanercept (1)  ·  Filgrastim (1)

Sponsors

Cairo University (4)  ·  Amgen (3)  ·  Instituto Nacional de Cancer, Brazil (2)  ·  Swedish Orphan Biovitrum (2)  ·  University of Sao Paulo (2)  ·  Ain Shams University (1)  ·  Air Force Military Medical University, China (1)  ·  All India Institute of Medical Sciences (1)  ·  Basma Morsy (1)  ·  Biotec Pharmacon ASA (1)  ·  Centre Leon Berard (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  EMS (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Galera Therapeutics, Inc. (1)

Countries

United States (11)  ·  France (8)  ·  Brazil (7)  ·  Egypt (5)  ·  China (4)  ·  Germany (3)  ·  India (3)  ·  Canada (2)  ·  Iran (2)  ·  Puerto Rico (2)  ·  Spain (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Atul Sharma, MD,DM (1)  ·  Basma AA Zakaria, PhD (1)  ·  Brian M Feldman, MD, MSc (1)  ·  Carlos G Ferreira, MD, PhD (1)  ·  Christine B. Boers-Doets, MSc (1)  ·  Dietger Niederwieser, Professor (1)  ·  Donald T Tan, FRCS (1)  ·  Elizabeth J Phillips, MD (1)  ·  Erica N Lia, PhD (1)  ·  Flavia A de Orange, PhD (1)  ·  Gene Kennedy, MD (1)  ·  Gisela M Pina, DDS (1)

Results publications

PMID 10423050, PMID 15161841, PMID 15287367, PMID 15602019, PMID 16161031, PMID 16391299, PMID 16415901, PMID 16862549, PMID 17580258, PMID 18413833, PMID 18696746, PMID 18754720, PMID 19125084, PMID 19733615, PMID 20141576, PMID 21394411, PMID 21473845, PMID 21537592, PMID 21741230, PMID 21911312, PMID 22057503, PMID 22077475, PMID 22467697, PMID 24119379, PMID 25161649, PMID 25198431, PMID 26559740, PMID 26916845, PMID 31618127, PMID 34145168, PMID 35634695, PMID 38824583, PMID 41127563, PMID 42829889

NIH funding

2018 (1), 2025 (1), R01CA107080 (1)